Income Statement
The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Paying user area
Try for free
Allergan PLC pages available for free this week:
- Statement of Comprehensive Income
- Cash Flow Statement
- Common-Size Income Statement
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value (EV)
- Selected Financial Data since 2005
- Net Profit Margin since 2005
- Current Ratio since 2005
- Price to Earnings (P/E) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Allergan PLC for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Allergan PLC, consolidated income statement
US$ in thousands
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).
- Net Revenues
- Net revenues showed a moderate upward trend overall, starting at 15,071 million USD in 2015, dipping slightly to 14,570.6 million USD in 2016, then increasing to a peak of 16,089 million USD in 2019. The growth was somewhat steady, though 2018 saw a minor decline compared to 2017.
- Cost of Sales
- The cost of sales, excluding amortization and impairment of acquired intangibles, was highly volatile. It drastically dropped from -4,810.4 million USD in 2015 to -1,860.8 million USD in 2016, followed by a gradual increase to -2,493.1 million USD in 2019, indicating fluctuations in cost management or changes in cost structure.
- Gross Profit
- Gross profit showed a clear increase from 2015 to 2017, peaking at approximately 13,772.7 million USD. Subsequently, it plateaued around 13,596 million USD in 2018 and 2019, indicating stabilizing profitability at the gross level.
- Research and Development (R&D)
- R&D expenses exhibited a declining trend over the period, starting from -2,358.5 million USD in 2015 and decreasing to -1,812 million USD in 2019. This reduction may reflect a strategic shift or efficiency improvements in research investments.
- Selling and Marketing
- Selling and marketing costs increased overall, rising from -2,914 million USD in 2015 to -3,461.7 million USD in 2019, with some fluctuations. This suggests increased spending on sales efforts despite other cost reductions.
- General and Administrative Expenses
- General and administrative expenses varied considerably, initially decreasing from -1,765.6 million USD in 2015 to -1,271.2 million USD in 2018, followed by a substantial spike to -2,481.8 million USD in 2019, indicating possible restructuring or extraordinary expenses that year.
- Amortization, Goodwill, and Other Impairments
- Amortization expenses peaked in 2017 at approximately -7,197.1 million USD and then declined through 2019. Goodwill impairments were recorded only in 2018 and 2019 at significant levels (-2,841.1 million USD and -3,552.8 million USD respectively). Impairments related to in-process R&D, and asset sales showed irregular patterns but generally contributed negatively to overall expenses throughout the period.
- Operating Loss
- The company experienced operating losses each year, with losses deepest in 2017 and 2018 (-5,921.2 million USD and -6,247.6 million USD respectively), improving somewhat in 2019 to -4,445.3 million USD, reflecting operational challenges and large impairment charges.
- Interest Income and Expense
- Interest income was relatively low but stable, with a slight increase by 2019. Interest expense followed a declining trend from -1,193.3 million USD in 2015 to -783 million USD in 2019, likely due to debt reduction or refinancing activities.
- Other Income and Expenses
- Other items such as sale of businesses, debt extinguishment, and one-time fee activities were sporadic and contributed to volatility in overall financial results, with significant net negative impacts, notably in 2017 due to large impairments and other expenses.
- Income Taxes and Net Loss
- The provision for income taxes fluctuated substantially, providing significant benefits in some years (notably 2017 with 6,670.4 million USD benefit) but a slight charge in 2019. Net loss from continuing operations increased over time, peaking at -5,265.1 million USD in 2019. The net income figures were positive only in 2015 and 2016 driven by discontinued operations, but returned to losses from 2017 onward.
- Discontinued Operations
- Discontinued operations provided large positive income in 2015 and 2016, significantly boosting net income in those years. However, this ceased after 2016, contributing to losses in following years.
- Overall Profitability and Shareholder Impact
- Net income attributable to shareholders followed the net income trend, positive in early years but negative in later years, indicating deteriorating profitability. Dividends on preferred shares decreased over time, ending in 2019 with no reported amount, which may reflect changes in capital structure.